TG Branfalt

Oklahoma regulators have yet to license any laboratories to test products for the medical cannabis marketplace despite having already licensed more than 4,000 growers — the testing lab application process opens November 1.

Recent cannabis reforms legalizing possession and home cultivation in the Australia Capital Territory will have “no effect” because it does not address differences in federal law, says Australian Attorney-General Christian Porter.

Four medical cannabis patients in Massachusetts have asked to join a lawsuit challenging the state’s four-month vaporizer ban approved last month by Gov. Charlie Baker.

Former Veterans Affairs Secretary David Shulkin has called on the federal government to eliminate the “hoops” making cannabis research so difficult.

The United Natural Products Alliance has added its first CBD company to its ranks and released rules for accepting additional industry members.

New Mexico may approve social-use locations for licensed medical cannabis patients in the state. The changes also address out-of-state reciprocity.

The Arthritis Society of Canada has called for medical cannabis products to be available on pharmacy shelves; the group also called for ending the $1 per gram federal excise tax on cannabis.

Regulators in the UK have banned a $2.56 million ad campaign for Dead Man’s Fingers, a hemp CBD-infused rum product from Cornish Rum Company that leaned on cannabis innuendos in its marketing strategies.

A new RE/MAX housing report found that Canada’s legal cannabis industry has driven up housing prices in regions with successful cannabis operators, despite warnings from anti-legalization advocates that the opposite would happen.

Brad Bogus is the VP of Growth and Marketing for Confident Cannabis, a wholesale cannabis platform that connects cannabis cultivators, laboratories, and retailers.

Pennsylvania lawmakers have proposed an adult-use cannabis legalization bill that includes home cannabis cultivation, delivery, social-use, and expungement; the bill would also establish commercial micro-grow permits capped at $250 per year, with large-scale grows costing $10,000 annually with a $100,000 application fee.

Two of Florida’s high-priced medical cannabis licenses are up for sale for a proposed $95 million — $40 million for one, $55 million for the other (which includes a greenhouse and a higher allowance for retail locations).

The United Kingdom has given a license to Canada’s Canopy Growth that allows the company to import bulk medical cannabis products into the UK.

Troubled Canadian cannabis operator CannTrust is set to destroy $65 million in inventory and $12 million worth of biological assets as part of its remediation plan to get its license back.

Denver-based cannabis cultivator Bonsai Cultivation is recalling loose flower products and pre-rolls due to high yeast and mold counts; at least 45 companies have been affected by the recall.

UC San Diego researchers are set to receive $3 million from the state, which will be split between five different CBD research projects.

The latest medical cannabis law in California allows parents to administer medical cannabis treatments to their children on K-12 school campuses.

The Texas medical cannabis dispensary applications portal was shut down without warning after just one week on the Texas Department of Public Safety’s website.

Quebec’s government announced it will appeal a recent court decision that ruled the province’s ban on home cannabis cultivation is unconstitutional.

Post-legalization policies proposed by the American Trucking Associations would lift restrictions on cannabis research, allowing for studies into the impact of cannabis-impaired driving.

Oklahoma state officials have approved 200,000 medical cannabis applications since the application process launched last year — that’s an average of 3,500 new patients per week.

The Pennsylvania American Civil Liberties Union filed suit against Lebanon County after officials decided to stop allowing people who are on parole or probation from participating in the state medical cannabis program.

The acquisition deal between MedMen and PharmaCann has been called off; the companies announced the deal’s termination as “mutual.”

The East Coast’s first commercial outdoor cannabis crop has been harvested in Maryland; licensed producers in the area typically grow indoors and in greenhouses.